Introduction
Disorders of iron metabolism, either deficiency or overload, have been associated with increased cardiovascular morbidity and mortality.
1 -3 Severe iron overload, owing to acquired and genetic haemochromatosis, has been consistently associated with cardiomyopathy and a higher incidence of heart failure (HF).
1 Iron overload cardiomyopathy is found in patients with primary or secondary haemochromatosis and with ferritin levels between 539 and 7700 ng/mL, which represents a specific population with highly increased body iron stores. 4 However, to date, whether mild or moderate increases in iron storages are associated with higher risk of incident HF in the general population has not been addressed. Iron deficiency has been associated with impaired cardiac function and altered myocardial structure in animal models. 5 In humans, up to 73% of patients with HF 6, 7 were iron deficient in cross-sectional analysis. Moreover, low iron storage has been associated with worse cardiovascular outcome independent of anaemia in subjects with HF. 7 These data raise the possibility that iron deficiency might play a role in the physiopathogenesis of cardiac dysfunction. The present study evaluated whether iron imbalance, characterized by low or high ferritin serum levels, was associ-ated with an increased incidence of HF in a community-based population.
Methods

Study population
The Atherosclerosis Risk in Communities (ARIC) Study is a prospective cohort study of 15 792 subjects aged between 45 and 64 years at recruitment between 1987 and 1989. The rationale, design, and procedures have been published previously. 8 Participants were recruited in four different centres in USA: Forsyth County, North Carolina; Jackson, Mississippi; the northwest suburbs of Minneapolis, Minnesota; and Washington County, Maryland. Since the recruitment between 1987 and 1989 (visit 1), four other visits were performed, and the last one (visit 5) occurred between 2011 and 2013. The study was approved by Institutional review boards from each site, and all participants gave written consent.
For this study, we considered 1145 participants who had ferritin levels measured in visit 1 and evaluated the association between ferritin levels and incident HF through the period of follow-up from 1987 to 1989, to December 31, 2011 . This sample was free of diabetes at baseline and was originally enrolled in an case-cohort ARIC substudy that investigated the relationship between ferritin levels and incident type 2 diabetes ascertained through visit 4 (1996-1998). 9 We excluded patients with prevalent HF (n = 61) or unknown HF status at visit 1 (n = 21) leaving 1063 participants for this analysis.
Definition of incident heart failure
Incident HF was defined as the first occurrence of HF as either hospitalization according to the International Classification of Diseases, 9th Revision (ICD-9), code 428 (428.0-428.9) in any position obtained by ARIC Study retrospective surveillance of hospital discharges or a death certificate with death from HF in any position or death certificate with an ICD-9 code of 428 or an ICD-10 code of I50 among any of the diagnoses listed or underlying causes of death. 10 Death was ascertained through linkage with the National Death Index.
Ferritin measurement and definition of iron status
Ferritin level was measured using an immunoturbidimetric assay (Roche Diagnostics, Indianapolis, IN, USA). Plasma samples were collected at ARIC visit 1 and frozen at −70 ∘ C. The reliability coefficient for measures in 35 subjects with blinded replicate samples collected at visit 1 was 0.85. The lower limit of detection of ferritin was 3.4 ng/mL. Twenty five subjects had undetectable values that were imputed as 1.7 (half of lower limit detection value) for analyses.
Participants were categorized in three different groups according to ferritin serum levels: low ferritin (<30 ng/mL); 11, 12 normal ferritin (30-200 ng/mL in women and 30-300 ng/mL in men); and high ferritin (>200 ng/mL in women and >300 ng/mL in men). 4 In addition, as supplementary analysis, we divided participants into four groups adding a 'low-normal' ferritin group, which was defined by ferritin levels between 30 ng/mL and 100 ng/mL. we added a fourth ferritin category called 'high-normal', defined by ferritin between 200 ng/mL and 500 ng/mL in women and between 300 ng/mL and 500 ng/mL in men.
Covariates
Other definitions and information about demographic variables (age, gender, race), self-reported smoking and alcohol intake, diabetes, hypertension, and body mass index (BMI) were used as previously described. 13 Anaemia was defined as haemoglobin levels <12 mg/dL in women and <13 mg/dL in men at visit 1. Incident anaemia was ascertained when anaemia appeared during the follow-up. The daily iron intake was estimated by a semiquantitative food frequency questionnaire. Women were classified as being in postmenopausal status if they had no history of menstruation in the past two years. Data regarding use of non-steroidal anti-inflammatory drugs (NSAID) were obtained by means of an interviewer-administered questionnaire. Measurements of low-density lipoprotein (LDL) cholesterol, high-density lipoprotein cholesterol, glucose, C-reactive protein, haemoglobin, and albumin were performed as previously reported. 9 High education level was defined as college, graduate, or professional school attendance.
Statistical analyses
Descriptive data are presented as the mean ± standard deviation for normally distributed variables and median (25th percentile, 75th percentile) for non-normally distributed variables. Significant pairwise comparisons were adjusted for multiple testing using Bonferroni correction and are shown only for variables in which a significant global difference was detected using one-way ANOVA or Kruskal-Wallis tests. When appropriate, skewed variables were log transformed for analysis. The association between ferritin and covariates was assessed using linear regression. Categorical data were reported as per cent frequencies and compared by chi-square test. Incident HF was calculated and presented as events per 1000 person-years at risk.
The association between ferritin categories and incidence of HF was evaluated using Cox proportional hazards regression models that were weighted to account for the differences in the proportions of diabetes and race in the case-cohort sampling design. Three regression models were created: model 1 included age, gender, and race; model 2 also adjusted for BMI, heart rate, hypertension, smoking, alcohol drinking, haemoglobin, C-reactive protein, glucose, LDL cholesterol, glomerular filtration rate, and prevalent coronary disease; model 3 also adjusted for: albumin, menopausal status, education level, incidence of anaemia, and incidence of diabetes. We included a time-varying covariate to adjust for incident coronary heart disease (CHD). Cox regression analyses were performed in the whole sample (n = 1063) and in subjects without anaemia (n = 925). Kaplan-Meier survival analysis was used to compare the survival free of HF (hospitalization and death) among the three groups. The curvilinear association between ferritin and incident HF was assessed using restricted cubic splines with four knots adjusted for covariates included in model 1. Tests for interaction were performed using the likelihood ratio test for the cross-product interaction term between sex and ferritin categories. A sensitivity analysis was performed using only the non-diabetic participants to investigate whether the results would change after excluding subjects with incident diabetes. 61 (40) 241 (36) 74 (30) BMI, body mass index; CRP, C-reactive protein; GFR, glomerular filtration rate; LDL, low-density lipoprotein; NSAID, non-steroidal anti-inflammatory drug. * P < 0.05 low vs. normal ferritin. † P < 0.05 high vs. normal ferritin. ‡ Proportion among women in each group.
Two-sided P-values <0.05 were considered significant. All the statistical analyses were performed using Stata version 13.1 (Stata Corp., College Station, TX, USA).
Results
Population characteristics
The mean age of the study participants at baseline was 52.7 ± 5.5 years, 62% were women and 45% were black. The characteristics of the studied participants according to ferritin serum levels are described in Table 1 . The median ferritin level was 121 (56-226) ng/mL and among the 1063 ARIC participants who were included in our analysis, 153 (14%), 663 (62%), and 247 (23%) had low, normal-range and high ferritin levels, respectively. The univariate association between ferritin and the covariates is shown in the Supplementary material online, Table S1 . Subjects with low ferritin were younger, were more likely to be women, and had higher heart rate and lower haemoglobin levels than the normal range and high ferritin groups. Furthermore, low ferritin group had lower iron intake and were less likely to have reached menopausal status in comparison with other groups. Participants with high ferritin were more likely to be black, with higher blood pressure levels than other groups. In addition, BMI, and LDL cholesterol and glucose levels were higher in high-ferritin group than in the low and normal-range ferritin groups. 
Ferritin level and risk of incident heart failure
The mean follow-up was 21 ± 4.6 years, and incident HF occurred in 144 participants (13.5%). Subjects with low ferritin showed the highest rate of HF events in the whole sample [7.7 (5.2-11.4/1000)] and in non-anaemic participants [7.5 (4.7-12.0/1000)] among the groups studied ( Table 2) . Participants with high ferritin also had a higher rate of HF [6.9 (4.9-9.6/1000)] than the normal range group of individuals ( Figure 1 ). After adjusting for age, sex, race, BMI, heart rate, hypertension, smoking, alcohol drinking, haemoglobin, C-reactive protein, glucose, LDL cholesterol, glomerular filtration rate, prevalent coronary disease, albumin, menopausal status, incidence of anaemia, incidence of diabetes and education level, low ferritin levels were associated with a higher risk of HF [hazard ratio (HR) 2.24, 95% confidence interval (CI) 1.15-4.35] when compared with normal-range levels ( Table 3) . These results were reproduced when only participants without anaemia were included in the analysis. We also observed an increased risk in HF between participants with high ferritin levels (HR 1.81, 95% CI 1.01-3.25) when comparing with those with normal-range levels ( Table 3) . When adjusting for time-varying incident CHD, the association between low ferritin levels and incident HF remained significant (HR 2.06, 95% CI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . , and high ferritin (blue short dashed line) serum levels for the outcome of heart failure (hospitalization and death). Adjusted for age, sex, and race, standardized to a population that is 62% male, 55% white, and aged 50 years. (a) Whole sample; (b) only participants without anaemia were included. Low ferritin, <30 ng/mL; normal ferritin 30-200 ng/mL in women and 30-300 ng/mL in men; high ferritin, >200 ng/mL in women and >300 ng/mL in men. Hazard ratio (HR) was from a Cox regression adjusted for age, sex, and race. CI, confidence interval.
1.03-4.11; P = 0.040) while the association between high-ferritin and HF was no longer significant (HR 1.73, 95% CI 0.96-3.12; P = 0.068). When ferritin was split into four categories, considering individuals with values between 30 ng/mL and 100 ng/mL in a different group (low-normal ferritin), participants with low and high ferritin remained with a higher risk of HF. Subjects with low-normal ferritin were not significantly associated with incident HF (HR 1.32, 95% CI 0.65-2.66; P = 0.44; see the Supplementary material online, Table S2 ). Participants with high-normal ferritin did not have a significant higher risk of incident HF (HR 1.78, 95% CI 0.95-3.35; P = 0.072; see the Supplementary material online, Table S3 ).
When studying ferritin as a continuous variable, we found a curvilinear association between ferritin and incident HF with a U-shaped pattern in both the whole sample and in the subsample without anaemia (Figure 2) . all-cause mortality in adjusted models. There were no significant interactions between age or gender and ferritin levels on incident HF. We did find a different association between high ferritin and HF in those participants with incident diabetes. Non-diabetic participants with high ferritin had an increased risk of HF in comparison with participants with incident diabetes (P for interaction = 0.045).
In the sensitivity analysis restricted to the 538 participants without incident diabetes, there was an increased risk of HF among low-ferritin participants (HR 3.08, 95% CI 1.31-7.25; P = 0.010), in comparison with those with normal-range levels in the whole population. Among those without anaemia (n = 450 participants), low ferritin was also associated with a higher risk of HF (HR 3.37, 95% CI 1.36-8.37; P = 0.009) when compared with those with normal-range ferritin. In this subgroup without diabetes cases, we did not observe an increased risk of HF among participants with high-ferritin levels. 
Discussion
In a community-based sample of 1063 patients, iron imbalance, as characterized by either low or high ferritin serum levels, was associated with a higher risk of incident HF, even in non-anaemic participants. Overall, these findings suggest that both iron deficiency and iron overload might play a role in the development of HF. Markers of iron deficiency have been related to an increased incidence of cardiovascular disease, mainly myocardial infarction, CHD, and cardiovascular death, 2, 3 and worse outcomes in patients with HF. 7, 14, 15 However, to the best of our knowledge, the association with incident HF has never been tested. In the present study, we found that subjects with ferritin levels < 30 ng/mL had a 2.2-fold greater risk of HF than those with normal-range ferritin. Fourteen per cent of participants presented with low ferritin levels and these were mainly women, with a lower proportion in post-menopausal status, suggesting that perimenopause bleeding might be a contributing factor for low levels of iron storage among these women. In addition, a lower ingestion of iron in the diet was noted in comparison with those with normal or high ferritin levels. Neither iron intake or menstruation status was independently associated with incident HF, suggesting that these might be causal factors for iron deficiency but not an influence in the association between low ferritin and incident HF. Non-steroidal anti-inflammatory drugs are a clinically important cause of gastrointestinal bleeding, iron deficiency, and also are associated with development of HF. 16 Although we found a relatively high prevalence of NSAID usage among all individuals, there was no association with iron deficiency. Data regarding gastrointestinal bleeding, another potential cause of low-ferritin, was not available for inclusion in the present study. We used a regression model adjusted for demographic parameters, socioeconomic indicators, cardiovascular risk factors, and prevalent CHD. It is unlikely that malnutrition status might explain the higher HF incidence rates in subjects with low ferritin. Although albumin was slightly lower in the participants with low ferritin, the difference in albumin levels was not clinically important; besides, this potential confounder was included in the regression model. Anaemia is already known as a factor associated with new-onset HF 17 and cardiovascular disease. 18 As recently reported, haemoglobin serum levels <11 g/dL for men and <10 g/dL for women were associated with an increased incidence of HF in 8 years of follow-up when compared with normal haemoglobin level concentrations. 17 It is possible that anaemia plays a role in the mechanism linking iron deficiency and incident HF. Notably, in the present study, low ferritin levels were strongly associated with incident HF after excluding anaemic subjects at baseline and adjusting for incident anaemia, suggesting that iron deficiency is independently associated with incident HF. We also need to take into account the role of erythropoietin in this relationship. A recent study performed by Beverborg and colleagues 19 found that increased levels of serum erythropoietin are associated with new-onset HF in patients with albuminuria in the community. In the same study, individuals with high levels of erythropoietin had the lowest ferritin levels and a higher prevalence of anaemia than those with low levels of erythropoietin. It is possible that iron deficiency may be associated with high erythropoietin levels leading to HF.
Figure 2
Adjusted hazard ratio of heart failure in the whole population sample (a) and in non-anaemic participants (b) in function of ferritin (spline regression analysis; ARIC Study, 1987-2011). Data adjusted for age, sex, and race. The red lines represent the hazard ratios (HR) and the black dashed lines the 95% confidence intervals (CI). Ferritin = 121 ng/mL (median) was considered the reference for the whole population and ferritin = 127 ng/mL (median) for the non-anaemic population (HR = 1).
Unfortunately, in the present study, we do not have this biomarker available to analyse its influence in the association between ferritin and incident HF.
Different pathophysiological mechanisms can explain the association between low ferritin levels and incident HF. In conditions of iron deficiency, there is a reduction in concentration and activity of muscular oxidative enzymes and respiratory proteins, causing impairment in cellular energetics. 20 Concomitantly, structural alterations such as mitochondrial swelling and irregularities in sarcomere organization could develop. 5 Furthermore, iron deprivation affects the cell proliferation cycle, trigging G1/S phase mitotic arrest and apoptosis, 21 altering myocardial composition. Independently of the presence of anaemia, it might increase catecholamine levels, 22 contributing to cardiac hypertrophy. 23 Together, these intracellular and neurohormonal disarrangements might contribute to the development of HF in patients with iron deficiency. It has been estimated that iron deficiency affects 30% of adults in Western countries and 39% in Asia. 24 In the community, poor iron status affects work productivity, physical performance, and mental function; it has also been related to an increase in all-cause mortality in an elderly population. 25 Here, we did not find a significant association between ferritin levels and the risk of death. However, the association of a low ferritin level with incident HF in the general population is a factor that could have an impact on public health systems. The benefits of iron supplementation in terms of cardiovascular outcomes in the general population are not known. Previous studies found that the iron-supplemented women showed improvement in productivity and a significant decline in fatigue. 26 Among iron-deficient patients with chronic HF, treatment with iron has shown to improve functional capacity and quality of life. 27 Whether iron supplementation might reduce the incidence of HF remains unknown.
Iron overload cardiomyopathy has been described in patients with primary haemochromatosis and in transfusion-dependent anaemias.
1 Ferritin serum levels higher than 2500 ng/mL were . associated with a higher risk of HF in a previous report. 28 In the present study, we defined high ferritin as >200 ng/mL for women and >300 ng/mL for men, because we sought to include those subjects considered at a higher risk of developing iron overload cardiomyopathy, although without a significant cardiac siderosis.
1
In our community-based study, there was an increased risk of HF in the group with high ferritin, in whom the average ferritin level was 358 ng/mL, suggesting that moderately increased body iron storage might also be harmful to the heart. It is unlikely that only inflammatory conditions might explain the higher rates of HF in subjects with mild and moderately elevated ferritin levels. The association remains consistent after adjusting for C-reactive protein and for common cardiovascular diseases such as diabetes and hypertension. Other causes of iron overload such as hepatic diseases and malignancies might be considered for this discussion, but are unlikely to confound or mediate the relationship between high ferritin and HF. Although the association between iron overload and CHD is still controversial in the literature, 3, 29 our findings suggest that incident CHD is at least partly involved in the association because no significant relationship between high ferritin and HF was found after including a time-varying covariate for CHD. In addition, concomitant conditions, such as myocardial ischaemia, may act in synergy with iron overload to cause damage to the cardiomyocyte, in which iron overload accelerates the catalytic process leading to cardiomyopathy. 30 Consequently, the presence of iron in excess might make the myocardium vulnerable to other types of causal agents increasing the incidence of HF in the long term. These data suggest that patients with mild to moderate elevations in ferritin should be considered as having an increased risk of developing HF. Whether a different approach to reducing ferritin serum level would decrease the incidence of HF is a reason for further studies. Moreover, only about 2.5% of the general population is homozygous for haemochromatosis, 31 which likely explains why few cases of iron overload were found in the present study when we defined high ferritin as >500 ng/mL, limiting the power to detect an association with HF.
Limitations to the study
There are some limitations in our analyses that should be addressed. First, ferritin was the only marker of iron status investigated. Its serum level can also be elevated in inflammatory conditions and in certain liver diseases. 32 To minimize this limitation, C-reactive protein, an inflammatory marker, was included as covariate in the model for analysis. Furthermore, serum ferritin is considered the best single test for the diagnosis of iron status, being a highly specific indicator of iron deficiency. The cut-off point of 30 ng/mL was reported to provide better positive predictive values for iron-deficiency anaemia (92-98%) when studied in several populations, 11,12 which strengthens our findings associating low ferritin levels with HF. Interestingly, individuals with 'low-normal' levels (30-100 ng/mL) had no increase in the risk of HF. It is likely that in a general population without chronic disease or inflammation, 'low-normal' ferritin might not represent iron-deficient individuals, as suggested elsewhere. 33 Second, ferritin levels were available only at baseline. It is possible that ferritin values may have varied over time, which could have influenced the estimation of the relationship between its serum levels and HF. In our analysis, we included the incidence of anaemia in the follow-up as an approach to attenuate this potential limitation. However, further studies considering repetitive measures of iron status in the exposure variable may be needed to fully address this issue. Third, some can argue that a possible rationale for the relationship between iron deficiency and HF is the development of anaemia during follow-up, the low haemoglobin level being the causative factor of HF. In our model, we included incident anaemia as a covariate to control this confounder, and the effect of incident anaemia did not account significantly for the findings. Fourth, although multivariable Cox regression models were used, residual confounding and confounding by unmeasured factors cannot be ruled out. Fifth, we did not use reclassification indices to compare the models including ferritin against models without ferritin because these procedures do not allow weighted analysis and we used a sampling weights that were needed to analyse the data appropriately. Finally, this study sample was originally enrolled in an ARIC substudy that investigated the relationship between ferritin levels and incident type 2 diabetes, 9 half of the sample being diabetic patients, with oversampling of African-Americans in the ARIC cohort. We performed a weighted Cox regression to account for the differences in the proportions of diabetes and race. Furthermore, a sensitivity analysis was performed including only the non-diabetic participants to avoid the oversampling of incident diabetes.
Conclusion
Derangements in iron metabolism, demonstrated by either low or high ferritin serum levels, were associated with a higher risk of incident HF when compared with normal ferritin levels in this study population. These findings suggest that iron imbalance may play a role in the incidence of HF.
. 
Supplementary Information
Additional Supporting Information may be found in the online version of this article: Table S1 . Univariate regression coefficients between covariates and log-transformed ferritin serum levels (n = 1063). Table S2 . Hazard ratio of heart failure by ferritin serum levels split in four categories (low, low-normal, normal, and high ferritin). Table S3 . Hazard ratios of heart failure by ferritin serum levels split in four categories (low, normal, high-normal, and high ferritin).
